Cost-effectiveness analysis of second-line medical therapies in acromegaly: a real-life study
IntroductionAcromegaly is an uncommon disease with important comorbidity and economic cost. Although the pharmacological cost of second-line treatment for refractory acromegaly has been theoretically analyzed, real-life studies are needed.ObjectivesTo assess the use of pasireotide and pegvisomant in...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2025-04-01
|
| Serier: | Frontiers in Endocrinology |
| Fag: | |
| Online adgang: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1573721/full |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|